Trials / Unknown
UnknownNCT03578835
Bloodstream Infection Due to Multidrug-Resistant Organisms - Multicenter Study on Determinants of Clinical Outcomes
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 6,000 (estimated)
- Sponsor
- University Hospital Tuebingen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Continual surveillance of both community-acquired and nosocomial bloodstream infections for specific target organisms. Analysis of comorbidities, complications, bacterial resistance patterns, bacterial genomics (e. g. via WGS and MLST typing) for the determinants of clinical outcomes. The clinical outcomes are investigated both in the short-term (up until discharge) and the long-term (six months after index blood culture by standardized questionnaire). A predictive point-of-care score is to be developed based on these data to define high-risk patient populations requiring more intensive diagnostic and/or treatment regimens.
Conditions
Timeline
- Start date
- 2017-02-01
- Primary completion
- 2018-12-31
- Completion
- 2019-06-30
- First posted
- 2018-07-06
- Last updated
- 2018-07-06
Locations
6 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT03578835. Inclusion in this directory is not an endorsement.